KMTS Earnings Date & History
Kestra Medical Technologies Ltd (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Sep 13, 2026 at 1:28 AM ET
Kestra Medical Technologies Ltd
Health Care
- Next earnings date
- Monday, September 14, 2026
- Reporting session
- After Close
- EPS estimate
- $-0.63
- Revenue estimate
- $29.6M
KMTS earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Tuesday, July 14, 2026 | Q4 2026 | $-0.61 | $-0.67 | -10.3% | $28.6M |
| Tuesday, March 17, 2026 | Q3 2026 | $-0.61 | $-0.61 | -0.4% | $24.6M |
| Thursday, December 11, 2025 | Q2 2026 | $-0.60 | $-0.64 | -5.8% | $22.6M |
| Thursday, September 11, 2025 | Q1 2026 | $-0.77 | $-0.45 | +42.1% | $19.4M |
What the market is watching in KMTS's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, daily catalyst context and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next KMTS earnings date?
- Kestra Medical Technologies Ltd is scheduled to report on Monday, September 14, 2026 (After Close). Dates can change until the company confirms them.
- Does KMTS report before or after the market?
- The next report is scheduled after close.
- What EPS is expected for KMTS?
- Consensus EPS for the upcoming quarter is $-0.63, on revenue of $29.6M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
KMTS earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone, commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.